Cross-Sector entity
Nanovibronix is most often covered alongside Cellebrite DI, which appears in 2 of these 2 stories. Coverage clusters in markets, which accounts for 1 of those 2, with the remainder spread across 1 other category. We currently track 2 Cross-Sector stories that mention Nanovibronix, all published on March 10, 2026.
2 verified stories tracked
Last mentioned: Mar 10, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Nanovibronix is most often covered alongside Cellebrite DI, which appears in 2 of these 2 stories. Coverage clusters in markets, which accounts for 1 of those 2, with the remainder spread across 1 other category. We currently track 2 Cross-Sector stories that mention Nanovibronix, all published on March 10, 2026. Each carries 4 original sources on average.
Computed from the 2 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Nanovibronix. Shared-story counts are live from our verified record — not editorial picks.
Wall Street Zen has issued a series of ratings downgrades targeting a diverse group of companies including NanoVibronix, Cellebrite, MicroVision, and The Honest Company. These moves signal a shift in sentiment toward high-growth and speculative tech sectors as analysts re-evaluate valuation and performance metrics.
Wall Street Zen has issued a series of downgrades for several mid-cap technology firms, most notably cutting digital intelligence leader Cellebrite DI to Sell and sensor specialist Microvision to Strong Sell. These moves signal a cooling sentiment toward specialized forensics and hardware sectors as market conditions and valuation models tighten.
Source: dailypolitical.com · dailypolitical.com
